Overexpression of microRNA-143 inhibits growth and induces apoptosis in human leukemia cells

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2035-2042

  Shen, Jian Zhen ^a   Zhang, Yuan Yuan ^a   Fu, Hai Ying ^a   Wu, Dan Sen ^a   Zhou, Hua Rong ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; DNA methyltransferase; DNMT3A; Hsa miR 143; Leukemia

Indexed keywords

BCL2 RELATED PROTEIN A1; CASPASE 3; CASPASE 9; CHOLECYSTOKININ OCTAPEPTIDE; DNA METHYLTRANSFERASE 3A; MICRORNA 143; DNA (CYTOSINE 5) METHYLTRANSFERASE; MESSENGER RNA; MICRORNA; MIRN143 MICRORNA, HUMAN; PROTEIN BCL 2;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER INHIBITION; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHILD; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; SCHOOL CHILD; WESTERN BLOTTING; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APOPTOSIS; BONE MARROW CELLS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; CHILD; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SINCALIDE; YOUNG ADULT;

EID: 84898612234     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3078     Document Type: Article

References (38)

1. Pui CH, Mullighan CG, Evans WE and Relling MV: Pediatric acute lymphoblastic leukemia: Where are we going and how do we get there? Blood 120: 1165-1174, 2012
2. Marks DI: Treating the 'older' adult with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2010: 13-20, 2010
3. Colvin GA and Elfenbein GJ: The latest treatment advances for acute myelogenous leukemia. Med Health R I. 86: 243-246, 2003
4. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ and Cronin KA (eds): SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted on the SEER website, 2013
5. Fausel C: Targeted chronic myeloid leukemia therapy: Seeking a cure. Am J Health Syst Pharm 64: S9-S15, 2007
6. Mathers CD, Boschi-Pinto C, Lopez AD and Murray CJL: Cancer incidence, mortality and survival by site for 14 regions of the world. Global Programme on Evidence for Health Policy Discussion Paper No. 13 (World Health Organization), 2001
7. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011
8. Polychronakis I, Dounias G, Makropoulos V, Riza E and Linos A: Work-related leukemia: A systematic review. J Occup Med Toxicol 8: 14, 2013
9. Zhao H, Wang D, Du W, Gu D and Yang R: MicroRNA and leukemia: Tiny molecule, great function. Crit Rev Oncol Hematol 74: 149-155, 2010
10. Zhang B, Pan X, Cobb GP and Anderson TA: MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007
11. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M and Croce CM: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801, 2005
12. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, Andreeff M, Bloomfield CD, Byrd JC, Chan K, Wu LC, Croce CM and Marcucci G: MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113: 6411-6418, 2009
13. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J and Malumbres M: Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13: 496-506, 2008
14. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, Volinia S, Alder H, Liu CG, Rassenti L, Calin GA, Hagan JP, Kipps T and Croce CM: Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66: 11590-11593, 2006
15. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E and Dahlberg JE: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102: 3627-3632, 2005
16. Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH, Chadburn A, Tuschl T, Knowles DM and Tam W: MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: A potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 173: 242-252, 2008
17. Gefen N, Binder V, Zaliova M, Linka Y, Morrow M, Novosel A, Edry L, Hertzberg L, Shomron N, Williams O, Trka J, Borkhardt A and Izraeli S: Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia 24: 89-96, 2010
18. Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, Li P, Zhang W, Wu H, Feng N, Wang Z, Hua L and Wang X: MiR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Mol Cell Biochem 350: 207-213, 2011
19. Nicoloso MS, Spizzo R, Shimizu M, Rossi S and Calin GA: MicroRNAs - the micro steering wheel of tumour metastases. Nat Rev Cancer 9: 293-302, 2009
20. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T and Naoe T: Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci 98: 1914-1920, 2007
21. Chen HC, Chen GH, Chen YH, Liao WL, Liu CY, Chang KP, Chang YS and Chen SJ: MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer 100: 1002-1011, 2009
22. Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM and Michael MZ: MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg 97: 853-861, 2010
23. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N and Akao Y: Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 77: 12-21, 2009
24. Gao W, Yu Y, Cao H, Shen H, Li X, Pan S and Shu Y: Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 64: 399-408, 2010
25. Zhang H, Cai X, Wang Y, Tang H, Tong D and Ji F: MicroRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep 24: 1363-1369, 2010
26. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li JJ, Röcken C, Ebert MP, Kwok TT and Sung JJ: MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101: 699-706, 2009
27. Akao Y, Nakagawa Y, Hirata I, Iio A, Itoh T, Kojima K, Nakashima R, Kitade Y and Naoe T: Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther 17: 398-408, 2010
28. Kiyota M, Kuroda J, Yamamoto-Sugitani M, Shimura Y, Nakayama R, Nagoshi H, Mizutani S, Chinen Y, Sasaki N, Sakamoto N, Kobayashi T, Matsumoto Y, Horiike S and Taniwaki M: FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors. Apoptosis 18: 1437-1446, 2013
29. Dick FR, Armitage JO and Burns CP: Diagnostic concurrence in the subclassification of adult acute leukemia using French-American-British criteria. Cancer 49: 916-920, 1982
30. Batliner J, Buehrer E, Fey MF and Tschan MP: Inhibition of the miR-143/145 cluster attenuated neutrophil differentiation of APL cells. Leuk Res 36: 237-240, 2012
31. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R and Vyzula R: Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402, 2007
32. Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J, Chen HY and Sun XF: Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 26: 27-34, 2009
33. Clape C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F, Avancès C, Villalba M, Culine S and Fajas L: MiR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One 4: E7542, 2009
34. Liu H, Zhang SZ, Cai SR, Peng JP and Zheng S: Effect of microRNA143 expression on cell proliferation in colonic carcinoma. Zhonghua Zhong Liu Za Zhi 30: 498-501, 2008 (In Chinese)
35. Akao Y, Nakagawa Y, Iio A and Naoe T: Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. Leuk Res 33: 1530-1538, 2009
36. Robertson KD and Wolffe AP: DNA methylation in health and disease. Nat Rev Genet 1: 11-19, 2000
37. Shen L and Pili R: Posttranscription regulation of prostate cancer growth. Cancer J 14: 46-53, 2008
38. Smith EM, Boyd K and Davies FE: The potential role of epigenetic therapy in multiple myeloma. Br J Haematol 148: 702-713, 2010